| Name |
Hyaluronidase (Ovine) (USP);HYO 6A;Vitrase (TN) |
| Product |
VITRASE (Bausch & Lomb Incorporated) |
| Sequence |
LDFRAPPLIS NTSFLWAWNA PAERCVKIFK LPPDLRLFSV KGSPQKSATG QFITLFYADRLGYYPHIDEK TGNTVYGGIP QLGNLKNHLE KAKKDIAYYI PNDSVGLAVI DWENWRPTWARNWKPKDVYR DESVELVLQK NPQLSFPEAS KIAKVDFETA GKSFMQETLK LGKLLRPNHLWGYYLFPDCY NHNYNQPTYN GNCSDLEKRR NDDLDWLWKE STALFPSVYL NIKLKSTPKAAFYVRNRVQE AIRLSKIASV ESPLPVFVYH RPVFTDGSST YLSQGDLVNS VGEIVALGASGIIMWGSLNL SLTMQSCMNL GNYLNTTLNP YIINVTLAAK MCSQVLCHDE GVCTRKQWNSSDYLHLNPMN FAIQTGKGGK YTVPGKVTLE DLQTFSDKFY CSCYANINCK KRVDIKNVHSVNVCMAEDIC IEGPVKLQPS DHSSSQNEAS TTTVSSISPS TTATTVSPCT PEKQSPECLKVRCLEAIANV TQTGCQGVKW KNTSSQSSIQ NIKNQTTY |
| Type |
Peptide |
| Remark |
ATC code: B06AA03Chemical structure group: DG00190Product (DG00190): D04455 D04456<US> D06604<US> |
| Efficacy |
Adjuvant (spreading) |
| Comment |
Hyaluronidase [KO:K01197] [EC:3.2.1.35] |
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] B BLOOD AND BLOOD FORMING ORGANS B06 OTHER HEMATOLOGICAL AGENTS B06A OTHER HEMATOLOGICAL AGENTS B06AA Enzymes B06AA03 Hyaluronidase D04455 Hyaluronidase (Ovine) (USP) New drug approvals in the USA [br08319.html] New molecular entities and new therapeutic biological products D04455New drug approvals in the USA, Europe and Japan [br08328.html] Approval dates by FDA, EMA and PMDA D04455 |
| Other DBs |
CAS: 488712-31-8PubChem: 47206320 |
| LinkDB |
|